StockData
Corbus Pharmaceuticals Holdings, Inc. logo

Corbus Pharmaceuticals Holdings, Inc. (CRBP) stock

CRBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$3.01−0.37 (-10.81%)

Close on Nov 17, 2026Market cap $58.22MP/E –Yield –

Corbus Pharmaceuticals profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Corbus Pharmaceuticals's profit margin for the twelve months ending Mar 31, 2022 was -16680.5%. For fiscal 2021 it was -5176.4%, against -2826.1% the year before. The highest annual figure on record is -197.7% in fiscal 2019.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2021Dec 31, 2021-5176.4%−2350.3
FY2020Dec 31, 2020-2826.1%−2628.4
FY2019Dec 31, 2019-197.7%+956.8
FY2018Dec 31, 2018-1154.5%+174.2
FY2017Dec 31, 2017-1328.6%−282.4
FY2016Dec 31, 2016-1046.3%+318.8
FY2015Dec 31, 2015-1365.1%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2021Sep 30, 2021-2236.0%+599.6
Q2 FY2021Jun 30, 2021-12550.3%+757.2
Q1 FY2021Mar 31, 2021-2479.9%−796.8
Q4 FY2020Dec 31, 2020-1308.4%−275.5
Q3 FY2020Sep 30, 2020-2835.6%−2032.8
Q2 FY2020Jun 30, 2020-13307.4%−13314.8
Q1 FY2020Mar 31, 2020-1683.1%−291.8
Q4 FY2019Dec 31, 2019-1032.9%−134.9
Q3 FY2019Sep 30, 2019-802.8%+535.7
Q2 FY2019Jun 30, 20197.4%+1421.3
Q1 FY2019Mar 31, 2019-1391.3%−160.7
Q4 FY2018Dec 31, 2018-897.9%−23.2
Q3 FY2018Sep 30, 2018-1338.5%+745.2
Q2 FY2018Jun 30, 2018-1413.9%−836.8
Q1 FY2018Mar 31, 2018-1230.5%+784.6
Q3 FY2017Sep 30, 2017-874.7%−154.7
Q2 FY2017Jun 30, 2017-2083.7%–
Q1 FY2017Mar 31, 2017-577.1%–
Q4 FY2016Dec 31, 2016-2015.1%–
Q3 FY2016Sep 30, 2016-720.0%–

More Corbus Pharmaceuticals figures

See a number that looks wrong?